Reply to: Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer

Aditya Bardia

Barbara Pistilli

Department of Cancer Medicine, Gustave Roussy, Villejuif, France

Hope Rugo

Aditya Bardia, MD, MPH, Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, Massachusetts General Hospital Cancer Center, Boston, MA; Barbara Pistilli, MD, Gustave Roussy Cancer Center, Villejuif, France; and Hope Rugo, MD, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA